ArticleFrontiers in oncology2022

Efficacy and Safety of Recombinant Human Adenovirus Type 5 (H101) in Persistent, Recurrent, or Metastatic Gynecologic Malignancies: A Retrospective Study.

Jing Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.